Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704327 · ClinicalTrials.gov registry record
Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
A clinical trial, sponsored by Lahey Clinic.
- Terminated
- Registry status
- 170
- Enrollment target
NCT00704327: Clinical Trial study, sponsored by Lahey Clinic.
NCT00704327 is a clinical trial that was terminated before completion, run by Lahey Clinic. The registered enrollment target is 170 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00704327 was terminated before completion, sponsored by Lahey Clinic.
- TERMINATED
- Registry status
- 170 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether or not cerebral atrophy scores obtained from a brain MRI can correlate with Cognitive Test results. These results hope to demonstrate a link between cerebral ischemic/degenerative changes shown on the MRI and cognition functions results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2008-02 |
| Est. Completion | 2017-03 |
Why NCT00704327 stopped before completion
NCT00704327 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00704327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00704327 about?
NCT00704327 is a clinical study titled "Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition". The purpose of this study is to evaluate whether or not cerebral atrophy scores obtained from a brain MRI can correlate with Cognitive Test results. These results hope to demonstrate a link between cerebral ischemic/degenerative changes shown on the MRI and cognition functions results.
What is the current status of trial NCT00704327?
This trial is currently terminated. The enrollment target is 170 participants. The study started on 2008-02. Estimated completion is 2017-03.
Who is sponsoring clinical trial NCT00704327?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia